USPTO Patent Application for Visual Pathway Strengthening Methods
Summary
The USPTO has published a new patent application (US20260083744A1) for methods of treating visual impairment by strengthening visual pathways. The application was filed on September 26, 2025, by inventors Ming-Fai Fong and Robert D. Lamprecht.
What changed
This document is a USPTO patent application (US20260083744A1) for "METHODS TO STRENGTHEN VISUAL PATHWAYS." The application, filed on September 26, 2025, by inventors Ming-Fai Fong and Robert D. Lamprecht, discloses methods for treating visual impairment in subjects.
As this is a patent application, it does not impose immediate compliance obligations or penalties on regulated entities. However, it signifies potential future developments in pharmaceutical treatments for visual impairments, which may impact drug manufacturers and medical device makers in the long term.
Source document (simplified)
METHODS TO STRENGTHEN VISUAL PATHWAYS
Application US20260083744A1 Kind: A1 Mar 26, 2026
Inventors
Ming-Fai Fong, Robert D. Lamprecht
Abstract
Disclosed herein are methods of treating visual impairment in a subject.
CPC Classifications
A61K 31/529 A61K 31/662 A61P 27/02
Filing Date
2025-09-26
Application No.
19341461
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.